ANALISIS PENGGUNAAN OBAT ANTI TUBERKULOSIS PADA PASIEN TUBERKULOSIS PARU KASUS BARU RAWAT JALAN DI RUMAH SAKIT ATMA JAYA

  • YELFI UNTAG
  • Fitri Ayuni

Abstract

ABSTRACTTuberculosis (TB) is a contagious infectious disease caused by Mycobacterium tuberculosis. The prevalence of pulmonary tuberculosis incident was included in the top 10 highest disease at Atma Jaya Hospital. Therefore, the study of the analysis of the use of anti-tuberculosis drugs in patients with new cases of lung rational at Atma Jaya Hospital indispensable. The purpose of this study was to determine the profile and analyze the rationality of the use of anti-tuberculosis drugs used in outpatients suffering from pulmonary tuberculosis new cases over the period July 2013 - June 2014.

References

Christian, W., Gomes, FV Rabna, P., Gustafson, P., Aaby, P., I.M, Andersen, P.L., Glerup, H.& Sodemann, M., 2010. Vitamin D as Supplementary Treatment for Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 179 (9) : 843-850
Crofton, S.J., N. Horne dan F. Miller. 2002. Tuberkulosis Klinis. Edisi Kedua. Penerjemah: Muherman Harun. Jakarta: Widya Medika.Hlm.185-189.
Departemen Kesehatan Republik Indonesia. 2010. Pedoman Nasional Penanggulangan Tuberkulosis. Departemen Kesehatan RI. Jakarta.
Departemen Kesehatan Republik Indonesia. 2011. Pharmaceutical Care Untuk Penyakit Tuberkulosis, Direktorat Bina Farmasi Komunitas Klinik, Direktorat Jenderal Bina Kefarmasian dan Alat Kesehatan. Jakarta.
Gusti, A. 2003. Kekerapan Tuberkolosis Paru pada Pasangan Suami-Isteri Penderita Tuberkolosis Paru yang Berobat di Bagian Paru RSUP H. Adam Malik.FK-USU, Medan. Holmes, C.B., Hausler, H., Nunn.
Hekster ,Y., S. Natsch., R. de Jong., E. Heerdink., R. Herings and J. Van der Meer., 1998. Application of the ATC/DDD Methodology to Monitor Antibiotic Drug Use. Eur. J. Clin. Microbiol. Infect. Dis. 17:20-24
Konstantinos A. 2010. Testing for tuberculosis. Australian Prescriber 33 (1): 12–18.
Nouwen, J.L. 2006. Controlling Antibiotic Use and Resistance, Clinical Infectiousprivate hospital in Selangor in the period of October to December 2004. Available at: http://mfi.farmasi.ugm.ac.id/files/news/5._17-4-2007- riswaka.pdf. Diakses tanggal 15 Februari 2014.
World Health Organization. 2012. WHO global strategy for containment of antimicrobial resistence. Switzerland. Tersedia di www.who.int/globalstrategy. Diakses tanggal 15 Februari 2014.
World Health Organization. 2013. Global Tuberculosis Report 2013. World Health Organization 20 Avenue Appia, 1211-Geneva-27, Switzerland. Tersedia di www.who.int/tuberkulosis. Diakses tanggal 15 Februari 2014.
Published
2017-01-09
How to Cite
UNTAG, YELFI; AYUNI, Fitri. ANALISIS PENGGUNAAN OBAT ANTI TUBERKULOSIS PADA PASIEN TUBERKULOSIS PARU KASUS BARU RAWAT JALAN DI RUMAH SAKIT ATMA JAYA. Farmasains : Jurnal Ilmiah Ilmu-Ilmu Kefarmasian, [S.l.], v. 3, n. 1, p. 31-34, jan. 2017. ISSN 2086-6968. Available at: <http://journal.uhamka.ac.id/index.php/farmasains/article/view/120>. Date accessed: 26 sep. 2017.
Section
Articles

Keywords

Anti-Tuberculosis Drugs, rationality, ATC / DDD